Continue reading
Although market exclusivity for orphan drugs (drugs for rare diseases) and the related non-indication-related document and marketing protection are crucial for ensuring investment and innovation protection in the pharmaceutical industry, it has not yet been clarified how and...
Continue reading
Our colleague Dr. Marco Stief has been given the honor of contributing the chapters on the Unified Patent Court and Unitary Patent as well as on t...
Continue reading
Continue reading
Five female patent attorneys at Maiwald, spanning several age groups and practice areas, explain how the intellectual property firm encourages the career development of women and talented young professionals.
Continue reading
Eva Ehlich and Anja Fux of Maiwald discuss an EPO board ruling relating to the standard of disclosure concerning the novelty and sufficiency of a therapeutic effec...
Continue reading
Maiwald, a leading German IP law firm, has 45% female partners, emphasizing equality and diversity. The firm supports women's career advancement and attracts talented women through its inclusive culture. Clients, even in m...
Continue reading
Claus Schindele considers the legal complications regarding patent protection in the offshore wind sector, with a particular eye on Germany and the UK Patent protection in the offshore wind energy sector i...
Continue reading
Investment and innovation protection are closely linked in the pharmaceutical sector for the development and marketing of new medicinal products. In addition to patent protection, market exclusivity under pharmaceutical law, which creates a legally defined protection period ...
Continue reading
Continue reading
In her article published by Managing IP, Kerstin Wolff reports on a proposal approved by the European Parliament (EP) that support...
Continue reading
EU competition law in the context of technology transfer, license and settlement agreements: Since at least the initiation of the first pharma sector inquiry in 2008, the pharma industry has been under close and austere scrutiny of the EU Commission. In the first part of thi...
Continue reading
In the context of the effect-driven assessment of inventive step under the European Patent Convention (EPC) it is usually crucial for the outcome whether an Applicant/a Patentee can rely on a specific technical effect corresponding to an improvement over the prior art. In th...
Continue reading
SPC for pharmaceutical products are an important complement to patent protection which is often inadequate in commercial terms. SPCs are designed to ensure that originators can amortize their high investments in research and clinical trials. But unlike in the USA, for exampl...
Continue reading
In the trade journal Pharma Recht (46th year, 15 March 2024), Dr. Marco Stief deals with the competition law assessment of research, cooperation and development agreements, with special consideration of the Research and Development Block Exemption Regulation.
Continue reading
In a recent article published in GRUR 2024, 182 et seqq., Dr. Marco Stief and
Continue reading
In the latest article published by Managing IP, Dr. Eva Ehlich and Dr. Anja Fux summarise an EPO board ruling relating to substances and compositions in the contex...
Continue reading
Decision on inventive step casts new light on EBA’s ‘plausibility’ guidance - Dr. Eva Ehlich and Dr. Anja Fux talk about this in the latest article on Managi...
Continue reading
Rechtshandbuch Chemie-, Pharma- und Life-Sciences-Patente is a comprehensive guide to the law on chemical, pharmaceutical and life sciences patents, which
Continue reading
Following expiry of market exclusivity in March 2022 for the drug Gilenya® (active ingredient: fingolimod) used for the treatment of multiple sclerosis and an unexpected delay in the grant of the dosage patent on a second medical use following complaint proceedings, several...
Continue reading
An English, updated and improved version of the article written by Dr. Marco Stief and Dr. Anja Geller that was published in GRUR 2023, 931 ff. is now available on the website of the
Continue reading
The Patent Lawyer Editorial Board looks back at 2023 to summarize key cases and developments by jurisdiction. Influenced by several years of use,
Continue reading
In a recent article with the title "Repeated trademark filings: EUIPO Board addresses 'annoying' practice" published by Managing IP, Susanna...
Continue reading
In concluding a two-part series on springboard injunctions, Dr Marco Stief takes a deeper dive to explain their require...
Continue reading
In the first of two articles on the springboard doctrine, Dr Marco Stief explains how the protective effect of a patent can continue to have an im...
Continue reading
The creation of the unitary patent and the Unified Patent Court (“UPC”) heralds the beginning of a new era in patent law in Europe. The Agreement on a Unified Patent Court (“UPCA”) entered into force on 1 June 2023 when the new UPC finally began operations. The openi...
Continue reading
In a recent article published by Managing IP, Dr Marco Stief considers a regulatory proposal designed to promote antimicrobial R&D and addres...
Continue reading
On April 27, 2023, the European Commission presented four proposals for Regulations on supplementary protection certificates as part of the Intellectual Property Action Plan. In this article, Dr Gisela Grabow, toget...
Continue reading
Preliminary injunctions orders are commonly granted for pharmaceutical patents. If an order later proves to be unfounded, under § 945 German Code of Civil Procedure (ZPO) the defendant generic company can claim damages on the basis of the plaintiff's strict liability. Howev...
Continue reading
On April 27 2023, the European Commission presented a proposal for the reform of the general pharmaceutical legislation in the EU. The proposal is based on
Continue reading
On April 27, 2023, the EU Commission presented a proposal for the reform of the pharmaceutical legislation in the EU. The proposal would lead to broad and far-reaching changes to the Regulation and the Directive, providing, for example for variable protection periods (standa...
Continue reading
by Dr Marco Stief Since 1989, it has been possible under Texas law to divide a business corporation into individual entities by way of a so-called "divisive merger"...
Continue reading
In its judgment of December 1 2022 (Case No. I ZR 144/21), the German Federal Court of Justice (FCJ) clarified several important points, which Dr Christian Meyer discusses in more detail in his article. Firstly, t...
Continue reading
In the article "The role of patent attorneys in patent infringement disputes in Germany and Europe", published by Managing IP, Dr-Ing. Bo-Hyun Lee considers how the Unified Patent Court will affect the successful Germ...
Continue reading
In the issue (No. 57) of "die Welt", Dr.-Ing. Sophie Ertl answered questions about the UPC as part of the supplement "Smart Rechtsguide": "Unitary Patent and Unitary Patent Court - what you need to know".
Continue reading
In the contribution in the 12/2023 issue of the BetriebsBerater journal, Dr Marco Stief reports on a ruling by the ECJ that significantly extends the liability of online platforms for third-party trademark infringemen...
Continue reading
Nicht immer ohne unerwünschte Nebenwirkungen – Einwendungen Dritter im Prüfungsverfahren vor dem Europäischen Patentamt: In seinem allgemeinen “Auftrags”-Statement verweist das Europäische Patent...
Continue reading
With the Second Act on the Simplification and Modernization of Patent Law (2nd PatMoG), German patent law has undergone significant changes. In particular, in §139 (1) S.3 PatG a proportionality barrier with regard to the right to injunctive relief under patent law was codi...
Continue reading
by Prof. Dr Maximilian W. Haedicke, Dr Marco Stief and Dr Annelie Wünsche The subjec...
Continue reading
In a recent article, published by MIP, Dr Marco Stief reports on a ruling by the CJEU that significantly extends the liability of online platforms for third-party trademark infringement and explains what it means for online marketplaces and trademark owners.
Continue reading
by Dr Marco Stief It is official: On 17.2.2023 Germany has now also ratified the Agreement on a Unified Patent Court (UPC) and thus the start of the new Unified Pat...
Continue reading
On August 17, 2021, the Second Patent Law Simplification and Modernization Act (2nd PatMoG) was proclaimed, resulting in several changes for patent law. In the article "Der patentrechtliche Verhältnismäßigkeitsgrundsatz im Bereich Arzneimittel und Medizinprodukte, Teil 1 ...
Continue reading
In the article "No-Challenge and Pay-for-delay Agreements in Patent License and Settlement Agreements under European Competition Law," recently published by the Journal of IP Law & Practice (Oxford University Press), ...
Continue reading
by Dr Marco Stief The introduction of the European patent and court system is causing significant upheaval and requires owners of European patents to take precautio...
Continue reading
by Dr Marco Stief with Dr Anna Giedke, Dipl. jur. Selina Stachowitz With effect from 1 January 2023, new versions of the R&D- and Specialisation-BER should...
Continue reading
Intellectual property can be utilised commercially in many ways. In addition to the traditional forms – such as the granting of licences, selling, and the judicial enforcement of cease-and-desist orders and claims for damages – IP can also be used as collateral for loans...
Continue reading
This year IAM has once again invited top IP strategists to tell readers more about their careers in intellectual property, top lessons learned along the way and their views on the current state of the market. Like IAM Global Leaders, which features top-ranked private practic...
Continue reading
Dr Marco Stief of Maiwald explains a ruling by the Düsseldorf Regional Court in the matter NuCana v Gilead that establishes the subsidiarity of the objection of disproportion...
Continue reading
Market leaders in the life sciences are interested in acquiring start-ups in order to acquire a new technology as soon as their investment risk can be better foreseen. In order to minimise the associated risks, a precise IP due diligence is required on the acquirer's side. I...
Continue reading
In the current edition of the JUVE Handbook for Commercial Law Firms 2022/2023 published in October 2022 Dr Marco Stief,
Continue reading
In this article, Dr Marco Stief discusses the admissibility of value maintenance and price adjustment clauses in commercial contracts. After many years of relative...
Continue reading
In their contribution, Dr Marco Stief and Heike Röder-Hitschke focus on the Unified Patent Court (UP...
Continue reading
Susanna Heurung examines a decision by the European Court of Justice concerning the ending of a period of ‘acquiescence’ in a trademark case and what it means for potential plaintiffs
Continue reading
by Dr Derk Vos The contribution highlights recent ECJ decisions regarding Article 3(a) of the SPC Regulation relating to one of the core aspects of SPCs – namely, th...
Continue reading
In the September edition of Managing Intellectual Property Susanna Heurung explains that owners of German trademarks who rely on their use in Switzerland must change their...
Continue reading
SPCs are currently based on Regulation (EC) No. 469/2009 on the supplementary protection certificate for medicinal products. Under a current EU initiative, the Commission is proposing, among other things, a single granting procedure and a single SPC system. In order to be ab...
Continue reading
In the issue 6/2022 of Pharma Recht, Dr Marco Stief and Dr Christian Meyer review and summarise the rather game-changing legal and factual developments in ...
Continue reading
The reach of Sec. 10(3) of the German Patent Act (GPA) has been the subject of debate by German patent courts for many years. Final clarification by the German Supreme Court is still awaited on the extent to which third parties are liable for their own supplying acts which d...
Continue reading
In the Special Report of Leaders League, Dr Christian Meyer explains how the new claim for compensation, based on the Directive (EU) 2019/2161 of 27 November 2019 on consu...
Continue reading
In the July edition of Managing Intellectual Property Heike Röder-Hitschke discusses a significant European Court of Justice (CJEU) ruling, and how it will affect future practice in preliminary injunction pr...
Continue reading
Ulrich M. Gassner brought medical product law into his scientific focus at an early stage and shaped it over decades. The contributions in this publication on the occasion of his 65th birthday deal with numerous facets of his work. The book contains texts by his students and...
Continue reading
In an article just recently published in the journal Arzneimittel & Recht (Edition 03/22) Dr Gisela Grabow and Dr Marco Stief discuss the grant ...
Continue reading
In her publication "Patents: New Principles in preliminary injunction proceedings",
Continue reading
Dr Simon Lud explains in Managing Intellectual Property how a German court judgment is advantageous for patent applications in the fields of artificial intelligence and quantum computing.
Continue reading
In the second part of the recently published article on contractual IP warranties, Dr Marco Stief discusses (1) limitations and restrictions of liability and (2) contractual indemnification obligations, both in the conte...
Continue reading
In the current issue of PharmR, Maiwald partner Dr Marco Stief takes a close-up look at contractual IP warranties, more specifically in the context of contracts regarding M&am...
Continue reading
Dr Matthias Hoffmann discusses in Managing Intellectual Property the uncertainty over the transfer of priority rights and the joint applicants approach at the EPO.
Continue reading
Dr Christian Meyer discusses in a publication of Managing Intellectual Property a case concerning the domain muenchen.de, in which a reference to a USB stick was found to ...
Continue reading
We are delighted to announce the release of the 2nd Edition of the Handbook “The Supplementary Protection Certificates (SPC)” edited by our partner Dr. Marco Stief. The book provides a detailed insight into t...
Continue reading
In the current edition of the JUVE Handbook for Commercial Law Firms 2021/2022 published in October 2021 Dr Eva Ehlich,
Continue reading
by Dr Stefanie Parchmann i...
Continue reading
by Dr Gisela Grabow in Managing Intellectual Property
Continue reading
by Dr Marco Stief In the current October issue of Pharma Recht - a specialist journal for pharmaceutical law our partner Dr. Marco Stief has written an article with...
Continue reading
by Dr Marco Stief and
Continue reading
by Dr Christian Meyer in Managing Intellectual Property
Continue reading
by Dr Annelie Wünsche and Dr Stefanie Parchmann
Continue reading
by Dr Marco Stief and Boris Bromm The current manual offers a comprehensive collection of annotated contract models for all comm...
Continue reading
by Dr Sophie Ertl in ZEIT „Arbeitswelten der Zukunft“
Continue reading
by Dr Eva Ehlich and Dr Christian Schäflein in Smart Rechtsguide 2021
Continue reading
by Dr Eva Ehlich and Angela Zumstein
Continue reading
by Dr Marco Stief and Heike Röder-Hitschke in Journal of Intellectual Property Law & Practice
Continue reading
by Dr Marco Stief and Dr Robert Wenzel in Journal of Intellectual Property Law & Practice
Continue reading
by Damla Simsek and Dr Stefanie Parchmann
Continue reading
by Dr Marco Stief in Managing Intellectual Property
Continue reading
by Dr Christian Meyer in Managing Intellectual Property
Continue reading
by Dr Derk Vos in IAM Innovation & Invention Yearbook: Building IP value in the 21st century This article first appeared in IAM Innovation & Invention Yearbook: Building IP value i...
Continue reading
by Dr Derk Vos in transkript - Life Science Magazine
Continue reading
by Dr Christian Pisani (together with Rebecca Koch) in Risikomanagement, Organisation, Compliance für Unternehmen Eds. Zenke / Schäfer / Brocke
Continue reading
by Dr Marco Stief in the GRUR - Zeitschrift der Deutschen Vereinigung für gewerblichen Rechtsschutz und Urheberrecht
Continue reading
by Dr Anja Friedrich in Managing Intellectual Property
Continue reading
by Dr Marco Stief and Dr Boris Bromm in Pharma Recht - Fachzeitschrift für das gesamte Arzneimittelrecht
Continue reading
by Stefan Bianchin in Managing Intellectual Property
Continue reading
by Dr Gisela Grabow in Managing Intellectual Property
Continue reading
by Dr Marco Stief and Dr Boris Bromm in Pharma Recht - Fachzeitschrift für das gesamte Arzneimittelrecht
Continue reading
by Dr Annelie Wünsche in Managing Intellectual Property
Continue reading
by Thomas Ederer in Managing Intellectual Property
Continue reading
2nd edition 2020 Eds. Haedecke / Timmann, edited i. a. by Dr Dirk Bühler and Dr Marco Stie...
Continue reading
Using the example of medical indications, excipients and combinations of active ingredients by Dr Marco Stief Publisher Carl Heymanns Verlag ISBN 97...
Continue reading
by Elke Wurster and Dr Christian Pisani in MPJ - Medizinprodukte Journal
Continue reading
by Stephan Schneller in Managing Intellectual Property
Continue reading
by Dr Eva Dörner and Alexander Ortlieb in Rechtsguide 2020 (insert of Süddeutsche Zeitung)
Continue reading
by Stefan Bianchin in Managing Intellectual Property
Continue reading
by Dr Ina Bürck in Study Guidelines, 2019 AIPPI Word Congress - London additional authors: Heiko Dumlich, Johannes Gierlich, Robin Keulertz, Simon Klopschinski, Philipp Marchand, Michael Schneider, Stefan Sc...
Continue reading
by Dr Christian Schäflein and Dr Fabian Kiendl in IAM Yearbook: Building IP value in the 21st century 2020 T...
Continue reading
by Dr Christian Meyer in Managing Intellectual Property
Continue reading
by Dr Volker Tegeder in Managing Intellectual Property
Continue reading
by Stephan Schneller and Samira Weik in World Trademark Review This article first appeared on WTR Daily, part of World Trademark Review, in (07/2019). For further information, please go to
Continue reading
by Sebastian Herzog in Managing Intellectual Property
Continue reading
by Dr Dirk Bühler in BioTechnologie Jahrbuch 2019
Continue reading
by Dr Martin Trautmann in Managing Intellectual Property
Continue reading
by Dr Marco Stief and Ulrike Zorr in Journal of Intellectual Property Law & Practice und GRUR Gewerblicher Rechtsschutz und Urheberrecht
Continue reading
by Dr Gisela Grabow in Managing Intellectual Property
Continue reading
by Dr Marco Stief and Ulrike Zorr in Managing Intellectual Property
Continue reading
by Dr Julia Mössinger in Managing Intellectual Property
Continue reading
by Dr Christian Haggenmüller in Managing Intellectual Property
Continue reading
by Dr Christian Pisani in Der Gynäkologe
Continue reading
by Dr Renate Rieder in Managing Intellectual Property
Continue reading
by Dr Annelie Wünsche in Managing Intellectual Property
Continue reading
by Simon Quartus Lud in Managing Intellectual Property
Continue reading
by Susanna Heurung in Managing Intellectual Property
Continue reading
by Norbert Hansen in Managing Intellectual Property
Continue reading
by Norbert Hansen in Managing Intellectual Property
Continue reading
by Eva Ehlich in European Patent Institute
Continue reading
by Simon Quartus Lud in Managing Intellectual Property
Continue reading
by Dr Annelie Wünsche in Managing Intellectual Property
Continue reading
by Marco Stief and Stefan G Fuchs in Managing Intellectual Property
Continue reading
by Marco Stief and Stefan G Fuchs in Managing Intellectual Property siehe auch Teil 2: Recent developments in German jurisprudence following ECJ Huawei Technologies / ZTE
Continue reading
by Norbert Hansen in Managing Intellectual Property
Continue reading
by Anja Friedrich in Managing Intellectual Property
Continue reading
by Marco Stief in Managing Intellectual Property
Continue reading
by Martina Müller-Dyck in Managing Intellectual Property
Continue reading
by Holger Kämpf in Managing Intellectual Property
Continue reading
by Stephan N. Schneller in World Trademark Review
Continue reading
by Fabian Kiendl in Managing Intellectual Property
Continue reading
by Marco Stief in Nature Biotechnology, Volume 33, Number 7
Continue reading
by Stephan N. Schneller in Nature Biotechnology, Volume 33, Number 7
Continue reading
by Simon Quartus Lud in Managing Intellectual Property
Continue reading
by Ralph Fernolend in Managing Intellectual Property
Continue reading
by Andreas Ledl in Managing Intellectual Property
Continue reading
by Norbert Hansen in Managing Intellectual Property
Continue reading
by Stephan N. Schneller in Managing Intellectual Property
Continue reading
by Stephan N. Schneller in Managing Intellectual Property
Continue reading
by Dirk Bühler in Managing Intellectual Property
Continue reading
by Marco Stief together with Dr. Dirk Bühler in Patent Law – A Handbook on European and German Patent Law, Haedicke/Timmann (Hrsg.)
Continue reading
by Marco Stief together with Dr. Dirk Bühler in Patent Law – A Handbook on European and German Patent Law, Haedicke/Timmann (Hrsg.)
Continue reading
by Marco Stief together with Dr. Dirk Bühler in Patent Law – A Handbook on European and German Patent Law, Haedicke/Timmann (Hrsg.)
Continue reading
by Marco Stief together with Heinrich Nemeczek in Managing Intellectual Property
Continue reading
by Norbert Hansen in Managing Intellectual Property <
Continue reading
by Stephan N. Schneller in Managing Intellectual Property
Continue reading
by Andrea Lasar in Managing Intellectual Property
Continue reading
by Sophie Ertl in Managing Intellectual Property
Continue reading
by Stephan N. Schneller in World Trademark Review
Continue reading
by Dr Derk Vos in Managing Intellectual Property
Continue reading
by Dr Dirk Bühler in Managing Intellectual Property
Continue reading
by Stephan N. Schneller in Managing Intellectual Property
Continue reading
by Matthias Gottschalk
Continue reading
by Norbert Hansen in Managing Intellectual Property
Continue reading
by Heike Röder-Hitschke in Götting/du Vall/Röder-Hitschke (Hrsg.)
Continue reading
by Andreas Ledl in Managing Intellectual Property
Continue reading
by Marco Stief zusammen mit Dr. Dirk Bühler in Handbuch des Patentrechts, Haedicke/Timmann (Hrsg.)
Continue reading
by Marco Stief zusammen mit Dr. Dirk Bühler in Handbuch des Patentrechts, Haedicke/Timmann (Hrsg.)
Continue reading
by Marco Stief zusammen mit Dr. Dirk Bühler in Handbuch des Patentrechts, Haedicke/Timmann (Hrsg.)
Continue reading
by Alexander Schmitz in Managing Intellectual Property
Continue reading
by Marco Stief together with Robert Wenzel in Managing Intellectual Property
Continue reading
by Marco Stief together with Dr. Stefan G. Fuchs in Managing Intellectual Property siehe auch Teil 1:
Continue reading
by Marco Stief together with Katja Bolender in Expert Guides
Continue reading
by Stefan Schneller in Managing Intellectual Property
Continue reading
by Simon Quartus Lud in Managing Intellectual Property
Continue reading
by Susanna Heurung in Managing Intellectual Property
Continue reading
by Dr Christian Schäflein in Ingenieurversteher
Continue reading
by Lutz Kietzmann in Managing Intellectual Property
Continue reading
by Heiko Dehm in World Trademark Review This article first appeared on WTR Daily, part of World Trademark Review, in (09/2017).
Continue reading
by Jan van Dieck in Managing Intellectual Property
Continue reading
by Dr Annelie Wünsche and Dr Dirk Bühler in Managing Intellectual Property
Continue reading
by Stefan Gross in Managing Intellectual Property
Continue reading
by Dr Simon Lud in Managing Intellectual Property
Continue reading
by Dr Klaus Breitenstein in Managing Intellectual Property
Continue reading
by Sybille Pfender in Managing Intellectual Property
Continue reading
by Dr Stefanie Parchmann in Managing Intellectual Property
Continue reading
by Attila Kimpan in European Consortium for Mathematics in Industry
Continue reading
by Dr Dirk Bühler in IAM Yearbook: Building IP value in the 21st century 2019
Continue reading
by Dr Sophie Ertl Interview with the Technical University Munich
Continue reading